SEC 13F Intelligence

Managers / Q2 2019 · view latest →

AXON CAPITAL LP

CIK 0001508755 · 126 EAST 56TH STREET, 30TH FLOOR, NEW YORK, NY, 10022 · (212) 479-2000

Reported Value
$48M
Q2 2019
Positions
8
Filings on Record
10
2019–present window
Filed
Aug 14, 2019
original filing

Summary

Axon Capital LP reported $48M in U.S.-listed holdings across 8 positions for Q2 2019.

The portfolio is heavily concentrated: PTCT alone accounts for 20.3% of reported value.

Compared with Q1 2019, the fund opened 1 new position and exited 0.

Portfolio Metrics

Turnover
+22.8%
vs prior filed quarter
Largest Position
+20.3%
Ptc Therapeutics

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $43MQ4 ’18Q1 ’19: $48MQ2 ’19: $48MQ2 ’19Q3 ’19: $37MQ4 ’21: $63MQ4 ’21Q1 ’22: $43MQ2 ’22: $42MQ2 ’22Q3 ’22: $23MQ4 ’25: $117MQ4 ’25Q1 ’26: $69Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 79.2%Other: 12.9%ADR: 7.9%
  • Common Stock · 79.2% · $38M
  • Other · 12.9% · $6M
  • ADR · 7.9% · $4M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
HUMHUMANA INCNEW+27.5K27.5K+$7M$7M
CNCCENTENE CORP DELTRIMMED118.7K38.6K$6M$2M
PTCTPTC THERAPEUTICS INCADDED+50.4K216.2K+$3M$10M
METAFACEBOOK INCTRIMMED11.3K39.2K$852,000$8M
STARS GROUP INCTRIMMED60.2K320.7K$1M$5M
GOOGALPHABET INCTRIMMED9705.4K$2M$6M
PLAYA HOTELS & RESORTS NVTRIMMED126.1K800.7K$899,000$6M
HDBHDFC BANK LTDHELD+029.2K+$413,000$4M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2019

8 positions
#IssuerClass% PortfolioValueShares
1PTCTPTC THERAPEUTICS INChistory →COM20.31%$10M216.2K
2METAFACEBOOK INChistory →CL A15.80%$8M39.2K
3HUMHUMANA INChistory →COM15.23%$7M27.5K
4PLAYA HOTELS & RESORTS NVSHS12.89%$6M800.7K
5GOOGALPHABET INChistory →CAP STK CL C12.19%$6M5.4K
6STARS GROUP INCCOM11.43%$5M320.7K
7HDBHDFC BANK LTDhistory →SPONSORED ADS7.93%$4M29.2K
8CNCCENTENE CORP DELhistory →COM4.23%$2M38.6K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$69M15May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$117M14Feb 12, 202613F-HRchanges · EDGAR ↗
Q3 2022$23M3Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$42M7Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$43M8May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$63M8Feb 11, 202213F-HRchanges · EDGAR ↗
Q3 2019$37M8Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$48M8Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$48M7May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$43M9Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.